Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME MSRB2 |
[1] |
Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Ethyl methanesulfonate up-regulates the expression of DME MSRB2 |
[2] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Butyraldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Butyraldehyde inhibits the expression of DME MSRB2 |
[3] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tunicamycin A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01494
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Tunicamycin A inhibits the expression of DME MSRB2 |
[4] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME MSRB2 |
[5] |
Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide inhibits the expression of DME MSRB2 |
[6] |
Azacitidine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00102
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Azacitidine up-regulates the expression of DME MSRB2 |
[7] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME MSRB2 |
[8] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME MSRB2 |
[9] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME MSRB2 |
[10] |
Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid inhibits the expression of DME MSRB2 |
[11] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME MSRB2 |
[12] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
GSK-J4 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01324
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
GSK-J4 inhibits the expression of DME MSRB2 |
[13] |
ICG-001 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
ICG-001 up-regulates the expression of DME MSRB2 |
[14] |
|
|
|
|
|
|